THE PROBLEM

2-5 days for targeted antibiotic treatment is not good enough

The challenges facing patients, physicians, and healthcare when sepsis and bloodstream infection are suspected are well documented. Increased risk of mortality, the high burden on healthcare budgets, and antimicrobial resistance all conspire to reduce the life chances of patients with sepsis when the time for effective treatment is a matter of life or death.

The standard of care for diagnosing a patient with suspected bloodstream infection is a system of culture-based methods that rely on the growth of organisms over 1-5 days where only then can the physician target antibiotics effectively.

This culturing step is a barrier to speeding up time-to-result for thousands of existing instruments and the adoption of newer, novel technologies.

OUR SOLUTION

SepsiSTAT® completes the job before culture delivers a first result

Momentum’s automated SepsiSTAT® system is a blood culture-independent process for extraction, concentration, and enrichment of living organisms giving identification and antimicrobial susceptibility results in hours not days.

Within the SepsiSTAT® system, a 12mL whole blood specimen is split into two simultaneous processes to deliver two products, SepsiTECT® and SepsiPURE®:

  • SepsiTECT® optimises proprietary technology that can universally detect viable bacteria and fungi at levels less than 2 cfu/mL together with molecular detection of Gram categories.
  • SepsiPURE® utilises highly efficient capture and concentration to isolate pure organisms for rapid growth and use in downstream applications providing vital identification, antimicrobial, and resistance information.

SepsiSTAT® uses one sample and two simultaneous processes to deliver results

render

AUTOMATED SAMPLE PROCESSOR

Momentum is developing an automated sample processor for random-access preparation of blood samples for SepsiTECT® and SepsiPURE®

The SepsiTECT® output can be analysed using any suitable qPCR instrument. The SepsiPURE® output is analysed using similar workflows to current standards.

ABOUT US

Driven by a global crisis

The team at Momentum Bioscience are creating innovative approaches that help healthcare professionals act faster and smarter when managing sepsis and bloodstream infection and to support the global challenge of antimicrobial resistance.

If you would like more information about our technology and investment opportunities, please complete the ‘contact us form’

CONTACT US

For more information please contact us by completing this form.

OXFORD

Research & Development
Momentum Bioscience Ltd
10 Blenheim Office Park
Fenlock Road
Long Hanborough
Oxon OX29 8LN

TEL: +44 (0)29 2167 7910

 

CARDIFF

Head Office
19 Willowbrook Technology Park
Crickhowell Rd
St. Mellons
Cardiff CF3 0EF

TEL: +44 (0)29 2167 7910

OXFORD

Research & Development
Momentum Bioscience Ltd
10 Blenheim Office Park
Fenlock Road
Long Hanborough
Oxon OX29 8LN

TEL: +44 (0)29 2167 7910

 

CARDIFF

Head Office
19 Willowbrook Technology Park
Crickhowell Rd
St. Mellons
Cardiff CF3 0EF

TEL: +44 (0)29 2167 7910

OXFORD

Research & Development
Momentum Bioscience Ltd
10 Blenheim Office Park
Fenlock Road
Long Hanborough
Oxon OX29 8LN

TEL: +44 (0)29 2167 7910

 

CARDIFF

Head Office
19 Willowbrook Technology Park
Crickhowell Rd
St. Mellons
Cardiff CF3 0EF

TEL: +44 (0)29 2167 7910

 

© 2022 Momentum Bioscience Ltd. All Rights Reserved.

Website by Hatch

© 2022 Momentum Bioscience Ltd.
All Rights Reserved.

Website by Hatch